Do Perform Light Challenge Tests for Transparent Containers During Stability Testing
Remember: Always include light challenge studies when testing products in transparent or semi-transparent containers — this confirms packaging suitability under ICH Q1B.
Why This Matters in GMP
Light exposure can degrade sensitive pharmaceutical ingredients, especially those stored in clear vials, bottles, or ampoules. A light challenge test simulates exposure to defined UV and visible light levels to assess potential degradation pathways. For transparent containers, this test is critical to determine if additional protective packaging (e.g., cartons, amber bottles) is required.
For example, if a vitamin-based syrup is stored in a clear PET bottle without a light shield and is not tested for photostability, degradation may occur during storage, affecting potency and color. Such deterioration may go unnoticed until consumer complaints or OOS results arise during routine testing.
Regulatory and Compliance Implications
21 CFR Part 211.166 requires testing of product stability under defined conditions, including light exposure when applicable. ICH Q1B outlines photostability testing strategies. WHO GMP and EU GMP require container-closure systems to be evaluated for protection against environmental factors.
Auditors review packaging qualification protocols, photostability data, and container selection rationale. Absence of light challenge
Implementation Best Practices
Conduct light challenge tests as per ICH Q1B using validated light chambers with specified lux and UV exposure. Evaluate product appearance, assay, impurities, and preservative content pre- and post-exposure. Compare results with samples stored in protective packaging as a control.
Document results in stability reports and include packaging justification. Train development and QC teams on light stability requirements and incorporate into container selection SOPs. Ensure labels also meet light-fastness requirements to prevent fading or delamination.
Regulatory References
– 21 CFR Part 211.166 – Stability testing protocols
– ICH Q1B – Photostability testing of new drug substances and products
– WHO TRS 1010, Annex 9 – Container integrity and photostability
– EU GMP Chapter 6 – Testing and packaging compatibility